{
  "docId": "019de076-aef8-73ee-832d-fdb26bc98608",
  "docSlug": "c95c061ca7ee3d0fc69daa81d5a345ff",
  "documentTitle": "Legend Biotech | Investor Presentation Deck | 14 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 14,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-aef8-73ee-832d-fdb26bc98608/12",
  "deckHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608",
  "deckJsonHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608.json",
  "deckAnchorHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.5,
        "y": 0.65
      },
      "kind": "list",
      "text": "Legend to conduct Ph1 for LB2102 in the US; Novartis to conduct all other development for the licensed products",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63a8dee4-da45-4244-884f-c2ef3cc5514b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.4,
        "y": 0.4
      },
      "kind": "metric",
      "text": "$1.01B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c42ddabc-c7ff-4a76-9f4d-cf79be93916f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.1,
        "y": 0.4
      },
      "kind": "metric",
      "text": "$100M",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4154e7b-b994-4d2a-af62-b5cf1cde37ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Legend announced on Nov 13, 2023 an exclusive, global license agreement with Novartis to advance certain DLL3-targeted CAR-T therapies, including LB2102, an investigational therapy for small cell lung cancer. Legend announced on Jan 3, 2024 closing of the license transaction.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92a60b4b-a346-40a4-8c95-3c0534fb7507",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.7,
        "y": 0.38
      },
      "kind": "subtitle",
      "text": "Tiered Royalties on Net Sales",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6a6da2cf-a2b8-484f-8b53-bff0c6280102",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Out-licensing Deal with Novartis on CAR-T Therapies Targeting DLL3",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7484db17-ebe0-430f-8c6f-2d88c9d08b79",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "b04d9cd7-1020-4566-b52a-4c31b36b05b9",
      "evidence": "paragraph/paragraph: Legend announced on Nov 13, 2023 an exclusive, global license agreement",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}